EXPE vs PMN · P/E 20, rev $7.74B vs P/E 4.8, $14.1M cap
Expedia Group Inc. (EXPE) versus ProMIS Neurosciences Inc. (PMN) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
ProMIS Neurosciences Inc. (PMN) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
PMN does not have a complete income-statement cache yet.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. PMN currently screens at market cap $14.1M and trailing P/E 4.8.
Not investment advice. Open the EXPE and PMN stock pages for the full models.
Not investment advice.